We therefore speculate that this TRβ-induced suppression of cancer cell growth may confer therapeutic effects on poorly differentiated and anaplastic thyroid carcinomas and that the underlying biochemical pathway may provide novel therapeutic targets for these cancers. This evidence concerns the gene THRB and thyroid gland undifferentiated (anaplastic) carcinoma.